Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors

Gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) is known to overexpress somatostatin receptors (SSTRs), most commonly SSTR2 and SSTR5. The expression of SSTRs on tumor cells forms the basis for somatostatin analog treatment of patients with NEN. The present study detected the expression of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncol Lett
Main Authors: Wang, Yuhong, Wang, Wei, Jin, Kaizhou, Fang, Cheng, Lin, Yuan, Xue, Ling, Feng, Shiting, Zhou, Zhiwei, Shao, Chenghao, Chen, Minhu, Yu, Xianjun, Chen, Jie
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2017
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403486/
https://ncbi.nlm.nih.gov/pubmed/28454229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5591
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki